Our Principal Investigator, Dr. Tomas Hajek, was just at the Schizophrenia International Research Society 2024 Conference in Florence, Italy. During his time there he presented in the symposium, Cardiometabolic Co-Morbidity in Schizophrenia Spectrum
Disorders – Unraveling the Mind-Body Interaction, specifically on his article, Trajectories of Daily Antipsychotic Use and Weight Gain/Metabolic Changes in People Hospitalized for First Episode of Psychosis.
Hajek Lab 
Leave a comment